Kranz H, Gutsche S
Pharmaceutical Technology, Bayer Schering Pharma AG, Berlin, Germany.
Int J Pharm. 2009 Oct 1;380(1-2):112-9. doi: 10.1016/j.ijpharm.2009.07.013. Epub 2009 Jul 24.
The major aim of this study was to identify an efficient tool to adjust drug release patterns from aqueous and organic ethylcellulose (a gastrointestinal insoluble polymer) coated pellets and to evaluate the long term stability of the film coatings. Drug release was monitored during open and closed storage at 25 degrees C/60% RH (ambient conditions) and 40 degrees C/75% RH (stress conditions) for up to 24 months. Release of vatalanib succinate, a poorly soluble drug that demonstrates pH-dependent solubility, from pure ethylcellulose coated pellets was slow irrespectively of the type of coating and release medium. By addition of the enteric polymer methacrylic acid/ethyl acrylate copolymer (applied as aqueous Kollicoat MAE 30 DP dispersion or organic solution of Kollicoat MAE 100 P) to ethylcellulose broad ranges of drug release patterns could be achieved. For aqueous film coatings the addition of Kollicoat MAE 30 DP to ethylcellulose dispersions resulted in unaltered drug release kinetics during closed storage at ambient and stress conditions. The storage stabilizing effect of the added enteric polymer might be explained by the more hydrophilic nature of Kollicoat MAE 30 DP compared to ethylcellulose trapping water during film formation and improving polymer particle coalescence. However, during open storage of aqueous coated ethylcellulose:Kollicoat MAE 30 DP pellets at stress conditions drug release decreased due to further gradual polymer particle coalescence. In contrast, drug release rates from organic coated ethylcellulose:Kollicoat MAE 100 P pellets stored at ambient and stress conditions did not change which could be explained by differences in the film formation process. This clearly indicates that the presented concept of the addition of methacrylic acid/ethyl acrylate copolymer to ethylcellulose film coatings in combination with an organic coating process is able to achieve broad ranges of drug release patterns and to overcome storage instability.
本研究的主要目的是确定一种有效的工具,用于调节水性和有机乙基纤维素(一种胃肠道不溶性聚合物)包衣微丸的药物释放模式,并评估薄膜包衣的长期稳定性。在25℃/60%RH(环境条件)和40℃/75%RH(加速条件)下进行开放和密闭储存,监测药物释放长达24个月。琥珀酸凡他尼布是一种难溶性药物,其溶解度依赖于pH值,无论包衣类型和释放介质如何,从纯乙基纤维素包衣微丸中的释放都很缓慢。通过向乙基纤维素中添加肠溶聚合物甲基丙烯酸/丙烯酸乙酯共聚物(以水性Kollicoat MAE 30 DP分散体或Kollicoat MAE 100 P有机溶液形式应用),可以实现广泛的药物释放模式。对于水性薄膜包衣,向乙基纤维素分散体中添加Kollicoat MAE 30 DP导致在环境和加速条件下密闭储存期间药物释放动力学不变。添加的肠溶聚合物的储存稳定作用可能是由于Kollicoat MAE 30 DP比乙基纤维素具有更强的亲水性,在成膜过程中捕获水分并改善聚合物颗粒的聚结。然而,在加速条件下开放储存水性包衣的乙基纤维素:Kollicoat MAE 30 DP微丸时,由于聚合物颗粒进一步逐渐聚结,药物释放减少。相比之下,在环境和加速条件下储存的有机包衣乙基纤维素:Kollicoat MAE 100 P微丸的药物释放速率没有变化,这可以通过成膜过程的差异来解释。这清楚地表明,将甲基丙烯酸/丙烯酸乙酯共聚物添加到乙基纤维素薄膜包衣中并结合有机包衣工艺的提出的概念能够实现广泛的药物释放模式并克服储存不稳定性。